ACO Name and Location

Health Point ACO, LLC
Previous Names: N/A
2055 Wood Street, Suite 100
Sarasota, Florida 34237

ACO Primary Contact

Primary Contact Name Neil Bedi, CEO
Primary Contact Phone Number 941-284-7264
Primary Contact Email Address nbedi@subserohealth.com

 

Organizational Information

ACO participants:

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Florida Medical Specialists, LLC. N

 

ACO governing body:

 

Member

Member’s Voting Power

Membership Type

ACO Participant TIN Legal Business Name/DBA, if Applicable

Last Name

First Name

Title/Position

BLANKENSHIP THOMAS CHAIRMAN #1 ACO Participant Representative Florida Medical Specialists, LLC
BEDI INITA SECRETARY #1 ACO Participant Representative Florida Medical Specialists, LLC
WARE JONATHAN DIRECTOR #1 ACO Participant Representative Florida Medical Specialists, LLC
COPPA MARGUERITE DIRECTOR Medicare Beneficiary Representative N/A

Key ACO clinical and administrative leadership:

Neil Bedi ACO Executive
Jonathan Ware Medical Director
Neil Bedi Compliance Officer
Neil Bedi Quality Assurance/Improvement Officer

 

Associated committees and committee leadership:

Committee Name

Committee Leader Name and Position

Compliance Committee Dr. Scott Clulow-Chairman
Quality & Clinical Informatics Committee Dr. Jonathan Ware-Chairman
Finance Committee Sarah Gay, CFO-Chairperson
Utilization Review Committee Dr. Daniela Kassabov-Chairperson

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement
  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Second Agreement Period
    • Performance Year 2018, $3,263,506
    • Performance Year 2017, $2,554,966
  • First Agreement Period
    • Performance Year 2016, $3,239,297
    • Performance Year 2015, $0
    • Performance Year 2014, $0

Shared Savings Distribution

  • Second Agreement Period
    • Performance Year 2018
      • Proportion invested in infrastructure: 0%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 50% to ACO Participants & 10% to ACO Providers/Suppliers.
    • Performance Year 2017
      • Proportion invested in infrastructure: 0%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 50% to ACO Participants & 10% to ACO Providers/suppliers
  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: 0%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 50% to ACO Participants & 10% to ACO Providers/suppliers
    • Performance Year 2015
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2014
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2018 Quality Performance Results:

ACO# Measure Name Rate ACO Mean
ACO-1

 

CAHPS: Getting Timely Care, Appointments, and Information

 

82.70

 

86.14

 

ACO-2

 

CAHPS: How Well Your Providers Communicate

 

91.19

 

93.93

 

ACO-3

 

CAHPS: Patients’ Rating of Provider

 

90.03

 

92.45

 

ACO-4

 

CAHPS: Access to Specialists

 

83.05

 

81.50

 

ACO-5

 

CAHPS: Health Promotion and Education

 

62.39

 

59.26

 

ACO-6

 

CAHPS: Shared Decision Making

 

64.49

 

61.94

 

ACO-7

 

CAHPS: Health Status/Functional Status

 

74.41

 

73.35

 

ACO-34

 

CAHPS: Stewardship of Patient Resources

 

28.76

 

26.26

 

ACO-8

 

Risk Standardized, All Condition Readmission

 

15.38

 

14.98

 

ACO-35

 

Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)

 

18.01

 

18.59

 

ACO-36

 

All-Cause Unplanned Admissions for Patients with Diabetes

 

33.95

 

37.01

 

ACO-37

 

All-Cause Unplanned Admissions for Patients with Heart Failure

 

80.10

 

76.75

 

ACO-38

 

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

 

59.43

 

59.00

 

ACO-43

 

Ambulatory Sensitive Condition Acute Composite (AHRQ Prevention Quality Indicator (PQI) #91)

 

1.73

 

1.98

 

ACO-11

 

Use of Certified EHR Technology

 

95.00

 

98.20

 

ACO-12

 

Medication Reconciliation Post-Discharge

 

97.75

 

85.91

 

ACO-13

 

Falls: Screening for Future Fall Risk

 

92.62

 

79.73

 

ACO-44

 

Use of Imaging Studies for Low Back Pain

 

0.00

 

64.36

 

ACO-14

 

Preventive Care and Screening: Influenza Immunization

 

84.60

 

72.71

 

ACO-15

 

Pneumonia Vaccination Status for Older Adults

 

86.58

 

75.97

 

ACO-16

 

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up

 

92.93

 

76.83

 

ACO-17

 

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

 

95.56

 

72.81

 

ACO-18

 

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

 

54.55

 

66.74

 

ACO-19

 

Colorectal Cancer Screening

 

73.45

 

68.27

 

ACO-20

 

Breast Cancer Screening

 

84.12

 

71.96

 

ACO-42

 

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

 

83.64

 

81.47

 

ACO-27

 

Diabetes Mellitus: Hemoglobin A1c Poor Control

 

10.36

 

15.51

 

ACO-41

 

Diabetes: Eye Exam

 

67.18

 

52.42

 

ACO-28

 

Hypertension (HTN): Controlling High Blood Pressure

 

81.37

 

73.10

 

ACO-30

 

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet

 

84.21

 

88.92

 

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size.

Note: In the Quality Performance Results file(s) above, search for “Health Point ACO, LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A2227 in the public use files on data.cms.gov.

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.

 

Public Website Disclosure Statement

The Centers for Medicare and Medicaid Services (“CMS”) and the U.S. Department of Health and Human Services’ Office of Inspector General (“OIG”) have made available waivers of certain federal fraud and abuse laws in connection with the operation of accountable care organizations (“ACOs”) that have entered into a participation agreement under the Medicare Shared Savings Program (“MSSP”).

In order to receive the benefit of such waivers, the governing body of Health Point ACO, LLC, a Florida limited liability company (the “Company”) has made a bona fide, detailed determination that the following arrangement is reasonably related to the purposes of the MSSP.

The Company has authorized a waiver of certain federal fraud and abuse laws for an arrangement by and among Subsero Health, LLC, a Florida limited liability company (“Subsero”) and KB Health Solutions, LLC a Florida limited liability company d/b/a Avidity Home Health (“Avidity”) and Corpas Home Health Care, LLC, a Florida limited liability company d/b/a Avidity Home Health (“Corpas”), whereby Subsero will provide care coordination and management services to Avidity and Corpas, and Avidity and Corpas will become preferred providers of the Company (the “Arrangement”).  Subsero functions as a management company for the Company, and Subsero and the Company share common ownership.

The governing body of the Company authorized the application of the waiver to the Arrangement on December 5, 2019, following a determination that the Arrangement supports the goals of the Company and is reasonably related to the purposes of the MSSP, in each case because the Arrangement is intended to: (i) avoid hospital readmissions; (ii) avoid or shorten skilled nursing facility or rehabilitation facility length of stays; (iii) enhance care coordination; (iv) decrease utilization on number of visits for home health; (v) maximize patient status with more enriched home health visits; (vi) leverage technology to get better outcomes (telehealth); (vii) educate patients earlier about hospice; (viii) reduce total cost of care for the episode; and (ix) reduce medical expenditures related to home care.